A 55-year-old female presented with
sore throat and slight
fever. The patient was admitted to our hospital on December 13, 1993. Full blood count showed
hemoglobin 10.7 g/dl, white cell count 960/microliters (neutrophils 14%, lymphocytes 82%, blasts 2%) and platelets 13,000/microliters. Bone marrow examination showed hypocellularity with 4.5% of myeloblast positive for
peroxidase. The bone marrow specimens on Dec. 20 showed 15.5% of myeloblasts, some of which had Auer rods. These findings led to the diagnosis of
refractory anemia with excess myeloblast in transformation (
RAEB-T) of French-American-British Cooperative Group. The patient was transfused and treated with
cytarabine ocfosfate (SP-AC) (100 mg tid) and
6-mercaptopurine (50 mg tid) for 14 days. During
chemotherapy she complained of
nausea and
anorexia, but they were managed easily with medication. On Feb. 7, 1994, forty-two days after the start of administration, peripheral blood and bone marrow aspirate were compatible with a complete remission. Although complete remission was sustained with courses of
chemotherapy for 4 months, relapse occurred and the patient died of
septicemia on August 29, 1994 after induction failure. Observation suggested that oral SPAC in combination with
6-mercaptopurine had a good antileukemic effect on the
myelodysplastic syndrome. However, the duration response was short, and further improvement of the
therapy is needed.